Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review von Garon, Edward B, Visseren-Grul, Carla, Rizzo, Maria Teresa, Puri, Tarun, Chenji, Suresh, Reck, Martin

Volltext

Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option von Park, Haeseong, Klempner, Samuel J, Chao, Joseph, Wainberg, Zev A, Lukanowski, Mariusz, Chenji, Suresh, Bourke, Shannon, Chatterjee, Anindya, Lorenzen, Sylvie

Volltext

375-P: Indirect Treatment Comparison (ITC) of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia: Baqsimi, Gvoke, and Zegalogue von GIMENEZ, MARGA, KHUNTI, KAMLESH, SYRING, KRISTEN, BAKER, LEVENIA A., CHENJI, SURESH, THRELKELD, REBECCA J., YAN, YU, MATSUHISA, MUNEHIDE

Volltext

Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia von Giménez, Marga, Khunti, Kamlesh, Matsuhisa, Munehide, Chenji, Suresh, Syring, Kristen, Yan, Yu

Volltext

Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus von Heise, Tim, Nosek, Leszek, Roepstorff, Carsten, Chenji, Suresh, Klein, Oliver, Haahr, Hanne

Volltext

On Modeling the Coexistence of 802.11 and 802.15.4 Networks for Performance Tuning von Wei Zhang, Suresh, Mahima A., Stoleru, Radu, Chenji, Harsha

Volltext